The Polish Society of Apitherapy was established to promote apitherapy—a field that uses bee products in the prevention and treatment of diseases, based on solid scientific foundations. We strive for apitherapy to be recognized as an effective and safe method for supporting health, grounded in scientific evidence and research
The Polish Society of Apitherapy is a guardian of quality in apitherapy, ensuring that standards are in line with the latest research and European and global norms. Only in this way can we ensure that apitherapy will be an effective, safe, and sustainable approach to health
Education is the cornerstone of our activity. The Polish Apitherapy Society aims to raise awareness of the health benefits of using honey, propolis, royal jelly, bee pollen, and bee venom. We want to reach both medical professionals and the general public, highlighting the value of natural therapies as a complement to traditional medical treatments.
We organize regular workshops, training sessions, and conferences where specialists share their knowledge and experience in the field of apitherapy. We ensure that our content is accessible and understandable for everyone – doctors, pharmacists, as well as individuals interested in natural medicine. Through these efforts, we also work to dispel myths and misunderstandings about bee product therapies, while promoting knowledge based on facts and research.
Moreover, our goal is to integrate apitherapy into medical practice as a recognized method of complementary treatment, promoting natural products as safe and effective. We believe that education can build trust in this form of therapy among both medical professionals and patients.
The development of apitherapy must be based on solid scientific foundations. The Polish Apitherapy Society actively supports and initiates research on the health properties of bee products. Our goal is to provide scientific evidence confirming the effectiveness of honey, propolis, bee venom, and other bee-derived substances in the treatment and prevention of various diseases, from infections to chronic conditions.
We collaborate with renowned research centers, universities, and experts in the fields of medicine, pharmacy, and biotechnology to jointly conduct studies on the use of bee products in the treatment of various diseases. Through this research, we aim to develop apitherapy as a field that combines modern science with traditional, natural healing methods. Our goal is to provide doctors and patients with reliable, research-based information about the effectiveness and safety of using bee products.
We also strive to discover new applications of apitherapy, working with scientists on the development of innovative treatment methods. We are constantly exploring new possibilities that may expand the use of bee products in various fields of medicine – from dermatology and immunology to cancer therapy
For apitherapy to become a widely accepted and safe form of treatment, it is essential to ensure high-quality standards for bee products. The Polish Apitherapy Society aims to establish and promote strict quality guidelines for products such as honey, propolis, royal jelly, and bee pollen that are used in therapy.
We are committed to ensuring that the products available on the market meet the highest standards of safety and efficacy. We work with producers, laboratories, and certification institutions to implement standards that guarantee the quality of raw materials and finished apitherapeutic products. We believe that only the highest-quality products, sourced from trusted suppliers, can provide the expected therapeutic effects and full safety for patients.
The Society is also involved in monitoring and evaluating products available on the market, publishing research results, and providing recommendations for choosing bee products. We support producers in their pursuit of excellence, while educating consumers to make informed decisions when selecting verified and safe products.
ul. Jana Nowaka-Jeziorańskiego 9/u6
03-984 Warszawa
contact@ptapi.pl
NIP: 1133129093
REGON: 528189514
KRS: 000109676
